Almost half of patients diagnosed with depression classify as being ‘treatment-resistant’ as new research suggests that many don’t respond to multiple antidepressant options. The new study, published in… read more.
Employee burnout is likely costing companies millions of dollars each year, ranging from approximately $4,000 to $21,000 per employee in the U.S., according to a study published in the American Journal… read more.
The FDA has approved monthly maintenance dosing for Leqembi (lecanemab), a treatment for early Alzheimer’s disease. The decision follows a supplemental application from Eisai, which is codeveloping Leqembi… read more.
Severe stress and trauma in childhood have been shown to negatively impact an individual’s health as an adult. Those affected face an increased risk of illness and often… read more.
A new study, led by experts at the University of Nottingham, has found that patients who need treatment for neurological and mental health disorders, would favour non-invasive neuromodulation… read more.
With New Year resolutions in full swing and health tracking apps at our fingertips, new research reveals concerning links between health and fitness apps and disordered eating, body… read more.
For teens who may be self-conscious about issues such as acne scarring or discolored teeth, non-surgical cosmetic procedures are an increasingly popular way to address their concerns. And… read more.
Calorie labels on restaurant menus are negatively impacting people with eating disorders, according to a new study published today in the BMJ Public Health. The review, which is the… read more.
Johnson & Johnson announced the FDA approval of a supplemental New Drug Application (sNDA) for Spravato (esketamine) CIII nasal spray, making this innovative treatment the first and only… read more.
There was a 65% increase in the number of children and young people being admitted to general acute medical wards in hospitals in England because of a mental… read more.
A new study suggests that boosting adolescent mental health is linked with long-term economic benefits. In contrast to similar findings from prior studies, these estimated relationships could be… read more.
A collaborative research group led by Professor Kenjiro Ono of the Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, and Eisai Co., Ltd., used a newly developed… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
